INTERIM CONSOLIDATED STATEMENTS OF CASH FLOW - USD ($) $ in Thousands	3 Months Ended
	Mar. 31, 2021	Mar. 31, 2020
Cash flow from operating activities:
Net income	$ 7,918	$ 8,120
Adjustments to reconcile net income to net cash provided by operating activities:
Depreciation and amortization	53,825	43,373
Amortization of above and below market leases	10	90
Amortization of deferred loan costs	1,130	987
Distributions from unconsolidated entity	569	300
Equity in net loss of unconsolidated entity	559	677
Equity-based compensation expense	6,856	4,875
Bad debt expense	1,013	3,719
Deferred tax expense (benefit)	18	(270)
Foreign currency remeasurement income	0	(159)
Changes in operating assets and liabilities
Rents and other receivables, net	(17,933)	2,888
Prepaid expenses	(3,914)	(3,164)
Due to/from affiliates, net	(4,095)	(4,428)
Other assets	(445)	(238)
Accounts payable and accrued liabilities	2,610	7,173
Advance rents, security deposits and other liabilities	3,771	6,727
Deferred income	8,203	392
Net cash provided by operating activities	60,095	71,062
Cash flow from investing activities:
Acquisitions, net of cash acquired	(401)	(1,797)
Additions to property and equipment	(214,279)	(171,218)
Net cash used in investing activities	(214,680)	(173,015)
Cash flow from financing activities:
Credit facility proceeds	253,000	212,917
Credit facility repayments	(280,000)	0
Payment of deferred financing costs	0	(5)
Payment of preferred stock dividends	(7,045)	(7,045)
Payment of common stock dividends	(30,352)	(25,627)
Distribution to noncontrolling interests	(3,082)	(2,934)
Proceeds from exercise of stock options	1,979	808
Payment of tax withholdings related to equity-based awards	(1,435)	(2,293)
Principal payments on finance lease obligations	(662)	(620)
Mortgage principal debt repayments	0	(12)
Common stock issuance proceeds, net of costs	215,923	83,260
Net cash provided by financing activities	148,326	258,449
Effect of foreign currency exchange rates on cash and cash equivalents	(1,864)	(192)
Net change in cash and cash equivalents	(8,123)	156,304
Cash and cash equivalents, beginning of period	22,775	15,653
Cash and cash equivalents, end of period	14,652	171,957
SUPPLEMENTAL DISCLOSURES OF CASH FLOW INFORMATION
Cash paid for interest	8,801	9,370
Noncash investing and financing activities:
Accrued capital additions	138,259	125,750
Net increase (decrease) in other assets/liabilities related to change in fair value of derivative contracts	17,253	(35,097)
Accrued equity issuance costs	75	44
Accrued preferred stock dividend	$ 5,938	$ 5,938